Caspase-activated DNase

Jump to navigation Jump to search
VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human
DNA fragmentation factor 40 kDa
File:PDB 1v0d EBI.jpg
Crystal structure of caspase-activated DNAse (CAD)
Identifiers
SymbolDFF40
PfamPF09230
InterProIPR015311
SCOP1v0d
SUPERFAMILY1v0d

Caspase-activated DNase (CAD) or DNA fragmentation factor subunit beta is a protein that in humans is encoded by the DFFB gene.[1][2][3] It breaks up the DNA during apoptosis and promotes cell differentiation. It is usually an inactive monomer inhibited by ICAD. This is cleaved before dimerization.

Function

Apoptosis is a cell death process that removes toxic and/or useless cells during mammalian development. The apoptotic process is accompanied by shrinkage and fragmentation of the cells and nuclei and degradation of the chromosomal DNA into nucleosomal units. DNA fragmentation factor (DFF) is a heterodimeric protein of 40-kD (DFFB) and 45-kD (DFFA) subunits. DFFA is the substrate for caspase-3 and triggers DNA fragmentation during apoptosis. DFF becomes activated when DFFA is cleaved by caspase-3. The cleaved fragments of DFFA dissociate from DFFB, the active component of DFF. DFFB has been found to trigger both DNA fragmentation and chromatin condensation during apoptosis. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene, but the biological validity of some variants has not been determined.[3]

File:CAD and ICAD forms.png
CAD and ICAD forms

Despite this gene being present in every cell, this protein is only expressed in different tissues and cell variety such as pancreas, heart, colon, leukocytes, prostate, ovary, placenta, kidney, spleen and thymus.[4]

It is also known as caspase activated nuclease (CPAN), dna fragmentation factor 40 (DFF-40), DFF2 and DFFB. Besides, there are other nomenclatures as a result of combining the previous ones.[4][5][6][7]

Structure

This heterodimer is an endonuclease[5][8][9] with a high content of cysteine residues.[7] It remains inactive in growing cells while it is associated with its inhibitor (ICAD, DNA fragmentation factor 45 kDa subunit, DFFA or DFF45) resulting into a complex ICAD-CAD.[4][5][7][8][10][11][12][13] Their dissociation allows DFF40 to oligomerize to form a large functional complex which is by itself an active DNase.[7][8][11][12][13]

DFF40 subunit or CAD

It weights 40 kDa. Moreover, it contains 3 domains making up a CAD monomer: C1 or N-terminal CAD; C2 which conform three separate α chains and, at last, C3 which is the largest and functionally the most important. What is more, combining C3’s amino acids leads to 5 α helices, 4 β lamina and a loop at the catalytic C-terminal which interact with each other. Therefore, a cavity (active site) where DNA can fit is produced, even though there is another binding region responsible for stable DNA complex during its fragmentation.[4][10][14]

DFF45 subunit or ICAD

DFFA is encoded by an alternatively encrypted mRNAs originating two distinct forms: short (ICAD-S) and long (ICAD-L), which act like a specific chaperone ensuring the correct CAD's folding[6][7][13] Besides, it contains two aspartic acid residues (Asp117 and Asp224) where CAD is identified and, consequently, it stays bounded until Caspase-3 splits this union.[6][10]

Activation process

Per usual in non-apoptotic growing cells caspase activated dnase is held in check inactivated in the cytoplasm thanks to the association with its inhibitor, inhibitor of caspase-activated DNase (ICAD) also known as DNA fragmentation factor 45 kDa (DFF45).

ICAD is encoded by alternatively spliced mRNAs which generate long (ICAD-L) and short (ICAD-S) forms of ICAD. Therefore, ICAD has a double function; it acts as a CAD inhibitor and also as a chaperone for CAD synthesis assisting the correct assembly of the protein.[15]

ICAD has two caspase recognition sites at Asp117 and Asp224. CAD release from ICAD inhibition is achieved by cleavage of ICAD at these Asp residues by the caspase-3.[16]

Caspase-3 is activated in the apoptotic cell.[5] Caspase-3 activation is a cell requirement during early stages of the skeletal myoblast differentiation. Its catalytic site involves sulfohydryl group of Cys-285 and the imidazole ring of its His-237. The caspase-3 His-237 stabilizes the target Aspartate causing the break of the association of ICAD and CAD leaving the endonuclease CAD active allowing it to degrade chromosomal DNA.

Once the inhibitor is released and in order to properly function, two CAD monomers need to come together to form a functional dimer that has vertical symmetry.

Interactions

DFFB has been shown to interact with DFFA.[17][18]

Cell differentiation

Caspase 3 is responsible for cellular differentiation, although it is unclear how this kind of protein can promote the cell apoptosis. Caspase signals resulting from the activation of nuclease CAD indicate that the cell differentiation is due to a CAD modification in chromatin structure.

CAD leads to the initiation of the DNA strand breakage, which occurs during terminal differentiation of some cell, such as skeletal muscle cell. Targeting of p21 promoter is responsible for inducing cell differentiation, which is promoted by modifying the DNA nuclear microenvironment.[19]

The cell diversity is originated by cell differentiation, which has been attributed to the activation of specific transcription factors. It also depends on the activity of a protein or a common signal. The factor that seems to induce more cell differentiation is caspase-3 protease.[20] This was identified as the penultimate stage of apoptosis pathways cell.

Some studies have shown that this differentiation is due to many CAD kinase substrates. Referring to the example of skeletal cells, their differentiation is associated to cleavage of the kinase MST1.[21]

Moreover, it has been seen that CAD participates in the formation of genome whose DNA breaks during early stages of the cell differentiation. Besides, Caspase 3 induces DNA breaks in the promoter of the factor p21 and this strand breakup is related to p21 gene expression.

Cell apoptotic death

The protein caspase DNase is an endonuclease involved in the cell apoptotic process that facilitates the DNA breakup.[22] Cell apoptotic death is a process executed by cysteine proteases[23] that allows the animals to keep their homeostasis, also regulated by other mechanisms such as the growth and cell differentiation. This biological response is characterized by the chromosomal DNA’s degradation in tiny fragments within the nucleus of the cell.[24] After many investigations and research, it was possible to ensure that Caspase-activated DNase is the main responsible of this destruction due to a long list of stimuli.

One of the experiments carried out by the investigators in order to prove that theory was based on the introduction of mutated form of this protein inside both TF-1 human cells and Jurkat cells, which had already reacted to the usual (not mutated) form of the endonuclease and they had dead of apoptosis. As a result, these cells died taking into account this genetic modification but they did not show DNA breakup. This was the key evidence to prove that the CAD form is implicated in this part of the process because without its contribution the fragmentation did not take place.[25]

Later, it was found out that the way how this protein induces the DNA breakup is explained by its forms CAD and ICAD, which facilitate both the entry and exit in the nucleus of the cell.[24]

References

  1. ↑ Liu X, Zou H, Slaughter C, Wang X (April 1997). "DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis". Cell. 89 (2): 175–84. doi:10.1016/S0092-8674(00)80197-X. PMID 9108473.
  2. ↑ Halenbeck R, MacDonald H, Roulston A, Chen TT, Conroy L, Williams LT (April 1998). "CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45". Current Biology. 8 (9): 537–40. doi:10.1016/S0960-9822(98)79298-X. PMID 9560346.
  3. ↑ 3.0 3.1 "Entrez Gene: DFFB DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)".
  4. ↑ 4.0 4.1 4.2 4.3 Davidson College. "Caspase Activated Deoxyribonuclease (CAD)". Retrieved 21 Jan 2016.
  5. ↑ 5.0 5.1 5.2 5.3 Yuste, Victor J.; Sánchez-López, Isabel; Solé, Carme; Moubarak, Rana S.; Bayascas, José R.; Dolcet, Xavier; Encinas, Mario; Susin, Santos A.; Comella, Joan X. "The Contribution of Apoptosis-inducing Factor, Caspase-activated DNase, and Inhibitor of Caspase-activated DNase to the Nuclear Phenotype and DNA Degradation during Apoptosis". The Journal of Biological Chemistry. Retrieved 16 October 2014.
  6. ↑ 6.0 6.1 6.2 Sakahira H, Iwamatsu A, Nagata S (March 2000). "Specific chaperone-like activity of inhibitor of caspase-activated DNase for caspase-activated DNase". The Journal of Biological Chemistry. 275 (11): 8091–6. doi:10.1074/jbc.275.11.8091. PMID 10713130.
  7. ↑ 7.0 7.1 7.2 7.3 7.4 Sakahira H, Enari M, Nagata S (May 1999). "Functional differences of two forms of the inhibitor of caspase-activated DNase, ICAD-L, and ICAD-S". The Journal of Biological Chemistry. 274 (22): 15740–4. doi:10.1074/jbc.274.22.15740. PMID 10336474.
  8. ↑ 8.0 8.1 8.2 Jog NR, Frisoni L, Shi Q, Monestier M, Hernandez S, Craft J, Prak ET, Caricchio R (April 2012). "Caspase-activated DNase is required for maintenance of tolerance to lupus nuclear autoantigens". Arthritis and Rheumatism. 64 (4): 1247–56. doi:10.1002/art.33448. PMC 3292632. PMID 22127758.
  9. ↑ Widlak P, Lanuszewska J, Cary RB, Garrard WT (July 2003). "Subunit structures and stoichiometries of human DNA fragmentation factor proteins before and after induction of apoptosis". The Journal of Biological Chemistry. 278 (29): 26915–22. doi:10.1074/jbc.M303807200. PMID 12748178.
  10. ↑ 10.0 10.1 10.2 Reh S, Korn C, Gimadutdinow O, Meiss G (December 2005). "Structural basis for stable DNA complex formation by the caspase-activated DNase". The Journal of Biological Chemistry. 280 (50): 41707–15. doi:10.1074/jbc.m509133200. PMID 16236713.
  11. ↑ 11.0 11.1 Widlak P, Li P, Wang X, Garrard WT (March 2000). "Cleavage preferences of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease) on naked DNA and chromatin substrates". The Journal of Biological Chemistry. 275 (11): 8226–32. doi:10.1074/jbc.275.11.8226. PMID 10713148.
  12. ↑ 12.0 12.1 Sharif-Askari E, Alam A, Rhéaume E, Beresford PJ, Scotto C, Sharma K, Lee D, DeWolf WE, Nuttall ME, Lieberman J, Sékaly RP (June 2001). "Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation". The EMBO Journal. 20 (12): 3101–13. doi:10.1093/emboj/20.12.3101. PMC 150191. PMID 11406587.
  13. ↑ 13.0 13.1 13.2 Liu X, Zou H, Widlak P, Garrard W, Wang X (May 1999). "Activation of the apoptotic endonuclease DFF40 (caspase-activated DNase or nuclease). Oligomerization and direct interaction with histone H1". The Journal of Biological Chemistry. 274 (20): 13836–40. doi:10.1074/jbc.274.20.13836. PMID 10318789.
  14. ↑ Uegaki K, Otomo T, Sakahira H, Shimizu M, Yumoto N, Kyogoku Y, Nagata S, Yamazaki T (April 2000). "Structure of the CAD domain of caspase-activated DNase and interaction with the CAD domain of its inhibitor". Journal of Molecular Biology. 297 (5): 1121–8. doi:10.1006/jmbi.2000.3643. PMID 10764577.
  15. ↑ http://www.rcsb.org/pdb/explore.do?structureId=1V0D#
  16. ↑ https://www.ncbi.nlm.nih.gov/gene/836
  17. ↑ Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, et al. (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry". Molecular Systems Biology. 3 (1): 89. doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
  18. ↑ McCarty JS, Toh SY, Li P (October 1999). "Study of DFF45 in its role of chaperone and inhibitor: two independent inhibitory domains of DFF40 nuclease activity". Biochemical and Biophysical Research Communications. 264 (1): 176–80. doi:10.1006/bbrc.1999.1497. PMID 10527860.
  19. ↑ Larsen BD, Rampalli S, Burns LE, Brunette S, Dilworth FJ, Megeney LA (March 2010). "Caspase 3/caspase-activated DNase promote cell differentiation by inducing DNA strand breaks". Proceedings of the National Academy of Sciences of the United States of America. 107 (9): 4230–5. Bibcode:2010PNAS..107.4230L. doi:10.1073/pnas.0913089107. PMC 2840077. PMID 20160104.
  20. ↑ Fernando P, Megeney LA (January 2007). "Is caspase-dependent apoptosis only cell differentiation taken to the extreme?". FASEB Journal. 21 (1): 8–17. doi:10.1096/fj.06-5912hyp. PMID 17093139.
  21. ↑ Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA (August 2002). "Caspase 3 activity is required for skeletal muscle differentiation". Proceedings of the National Academy of Sciences of the United States of America. 99 (17): 11025–30. Bibcode:2002PNAS...9911025F. doi:10.1073/pnas.162172899. PMC 123204. PMID 12177420.
  22. ↑ Lai SK, Wong CH, Lee YP, Li HY (June 2011). "Caspase-3-mediated degradation of condensin Cap-H regulates mitotic cell death". Cell Death and Differentiation. 18 (6): 996–1004. doi:10.1038/cdd.2010.165. PMC 3131938. PMID 21151026.
  23. ↑ Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM, Strasser A (October 2002). "Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome". Nature. 419 (6907): 634–7. Bibcode:2002Natur.419..634M. doi:10.1038/nature01101. PMID 12374983.
  24. ↑ 24.0 24.1 Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S (January 1998). "A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD". Nature. 391 (6662): 43–50. Bibcode:1998Natur.391...43E. doi:10.1038/34112. PMID 9422506.
  25. ↑ McIlroy D, Sakahira H, Talanian RV, Nagata S (August 1999). "Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli". Oncogene. 18 (31): 4401–8. doi:10.1038/sj.onc.1202868. PMID 10442630.

Further reading

Retrieved from "https://www.wikidoc.org/index.php?title=Caspase-activated_DNase&oldid=1530887"